⌘K

Login Start Free

Home/Filings/4/0001104659-25-068426

4//SEC Filing

Pinkas Jan 4

Accession 0001104659-25-068426

CIK 0001253689other

View on SEC.gov Company Profile

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 7:11 PM ET

Size

5.6 KB

Accession

0001104659-25-068426

Insider Transaction Report

Form 4

Period: 2025-07-16

CRESCENT BIOPHARMA, INC.CBIO

Chief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2025-07-16+142,474→ 142,474 total
Exercise: $13.14Exp: 2035-07-16→ Ordinary Shares (142,474 underlying)

Footnotes (1)

[F1]This option will vest as to 25% on July 7, 2026 and in equal monthly installments thereafter through July 7, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Documents

1 file

4
tm2521104-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CRESCENT BIOPHARMA, INC.

CIK 0001253689

Entity typeother

Related Parties

1

filerCIK 0002077126

Filing Metadata

Form type: 4
Filed: Jul 15, 8:00 PM ET
Accepted: Jul 16, 7:11 PM ET
Size: 5.6 KB

View on SEC.gov